The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans

APMIS

Volumn 105, Issue 11, 1997, Pages 875-883

  Samaranayake, Y H ^a   Samaranayake, L P ^a   Wu, P C ^b   So, M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antifungal; Candida albicans; Candida krusei; Lactoferrin; Lysozyme

Indexed keywords

ANTIFUNGAL AGENT; LACTOFERRIN; LYSOZYME;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA KRUSEI; CLINICAL ARTICLE; CONTROLLED STUDY; FUNGICIDAL ACTIVITY; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL;

EID: 0030730493     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1997.tb05097.x     Document Type: Article

References (38)

1. Arnold, R. R., Cole, M. F. & McGhee, J. R.: A bactericidal effect for human lactoferrin. Science 197: 263-265, 1977.
2. Arnold, R. R., Brewer, M. & Gauther, J. J.: Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect. Immun. 28: 893-898, 1980.
3. Arnold, R. A., Russell, J. E., Champion, W. J., Brewer, M. & Gauther, J. J.: Bactericidal activity of human lactoferrin: Differentiation from the stasis of iron deprivation. Infect. Immun. 5: 792-799, 1982.
4. Cole, M. F., Arnold, R., Mestecky, J., Kulhavy, R. & McGhee, J. R.: Studies with human lactoferrin and Streptococcus mutans. In: Stiles, H., Loesche, W. & O'Brien, T. (Eds.): Microbial Aspects of Dental Caries II. Information Retrieval, Washington, DC. 1976, pp. 247-359.
5. Collins, M. S. & Pappagianis, D.: Lysozyme-enhanced killing of C. albicans and Coccidioides immitis by amphotericin B. Sabouraudia, 12: 329-340, 1974.
6. Ellison, R. T., Giehl, T. J. & Laforce, F. M.: Damage of the outer membrane of enteric gram negative bacteria by lactoferrin and transferrin. Infect. Immun. 56: 2774-2881, 1988.
7. Epstein, J. B., Truelove, E. L. & Izutzu, K. T.: Oral candidiasis: pathogenesis and host defense. Rev. Infect. Dis. 6: 96-106, 1984.
8. Gibbons, R. J., de Stoppelaar, J. D. & Harden, L.: Lysozyme insensitivity of bacteria indigenous to the oral cavity of man. J. Dent. Res. 45: 877-881, 1965.
9. Iacono, K. J., Mackay, B. J., Dirienzo, S. & Pollock, J. J.: Selective antibacterial properties of lysozyme for oral micro-organisms. Infect. Immun. 29: 623-632, 1980.
10. Iacono, V. J., Boldt, P. R., Mackay, B. J., Cho, M. & Pollock, J. J.: Lytic sensitivity of A. actinomycetemcomitans Y4 to lysozyme. Infect. Immun. 40: 773-784, 1983.
11. Iacono, V. J., Zove, S. M., Grossbard, N. L., Pollock, J. J., Fine, D. H. & Greene, L. S.: Lysozyme-mediated aggregation and lysis of the periodontal micro-organism Capnocytophaga gingivalis 2010. Infect. Immun 47: 457-464, 1985.
12. Kamaya, T.: Lytic action of lysozyme on Candida albicans. Mycopathol. Mycol. Applic. 42: 197-207, 1970.
13. Keul, M.: The use of the studentized range in connection with an analysis of variance. Euphytica. 1: 112-122, 1952.
14. Kirkpatrick, C. H., Green, I., Rich, R. R. & Schade, A. L.: Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: Relation to host-defense mechanisms in chronic mucocutaneous candidiasis. J. Infect. Dis. 124: 539-544, 1971.
15. Lassiter, M. O., Newsome, A. L., Sams, L. D. & Arnold, R. R.: Characterization of lactoferrin interaction with Streptococcus mutans. J. Dent. Res. 66: 480-485, 1987.
16. Lodder, J.: The Yeasts: a taxonomic study, 2nd ed. Amsterdam, North Holland 1970.
17. MacFarlane, T. W. & Mason, D. K.: Changes in the oral flora in Sjögren's syndrome. J. Clin. Pathol. 27: 416-421, 1973.
18. Main, B. E., Calman, K. C., Ferguson, M. M., Kaye, S. B., MacFarlane, T. W., Mairs, R. J., Samaranayake, L. P., Willox, J. & Welsh, J.: The effect of cytotoxic therapy on saliva and oral flora. Oral. Surg. Oral. Med. Oral. Pathol. 58: 545-548, 1984.
19. Marquis, G., Montplaisir, S., Garzon, S., Strykowski, H. & Auger, P.: Fungitoxicity of muramidase -Ultrastructural damage to C. albicans. Lab. Invest. 46: 627-636, 1982.
20. Martin, M. V., Al-Tikriti, U. & Bramley, P. A.: Yeast flora of the mouth and skin during and after irradiation for oral and laryngeal cancer. J. Med. Microbiol. 74: 457-467, 1981.
21. Massons, P. L., Heremans, J. F. & Schonne, E.: Lactoferrin an iron-binding protein in neutrophilic leukocytes. J. Exp. Med. 130: 643-658, 1969.
22. Nikawa, H., Samaranayake, L. P., Tenouvo, J., Pang, K. M. & Hamada, T.: The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei. Arch. Oral. Biol. 38: 1057-1063, 1993.
23. Pollock, J. J., Iacono, V. J., Goodman, H., Mackay, B. J., Katona, L. I., Taichman, L. B. & Thomas, E.: The binding, aggregation and lytic properties of lysozyme. In: Stiles, H. M., Lobsche, W. J. & O'Brien, T. C.: (Eds): Proceedings: Microbial Aspects of Dental Caries. Information Retrieval Incorporated, Washington, DC. 1976, pp. 325-352.
24. Samuranayake, L. P., Calman, K. C., Ferguson, M. M., Kaye, S. B., MacFarlane, T. W., Main, B., Welsh, J. & Willox, J.: The oral carriage of yeasts and coliforms in patients on cytotoxic therapy. J. Oral. Pathol. 13: 390-393, 1984.
25. Samaranayake, L. P. & MacFarlane, T. W.: (Eds.): Oral Candidosis, Wright, Bristol 1990.
26. Samaranayake, Y., H., MacFarlane, T. W., Aitchison, T. C. & Samaranayake, L. P.: The in vitro lysozyme susceptibility of Candida albicans cultured in carbohydrate-supplemented media. Oral. Microbiol. Immunol. 8: 177-181, 1993a.
27. Samaranayake, Y. H., MacFarlane, T. W., Samaranayake, L. P. & Aitchison, T. C.: The in vitro lysozyme susceptibility of Candida species cultured in sucrose supplemented media. Microbios. 74: 23-28, 1993b.
28. Samaranayake, Y. H. & Samaranayake, L. P.: Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen. J. Med. Microbiol. 41: 295-310, 1994.
29. Scherwitz, C., Martin, R. & Ueberberg, H.: Ultrastructural investigation of the formation of Candida albicans germ tubes and septa. Sabouraudia 16: 115-124, 1978.
30. Silverman, S., Migliorati, C. A., Epstein, J. B. & Samaranayake, L. P.: Laboratory diagnosis of oral candidosis. In: Samaranayake, L. P., & MacFarlane, T. W. (Eds.) Oral Candidosis. Wright, London 1990.
31. Soukka, T., Lumikari, M. & Tenouvo, J.: Combined bactericidal effect of human lactoferrin and lysozyme against Streptococcus mutans serotype c. Microbial Ecol. Health Dis. 4: 259-264, 1991.
32. Soukka, T., Tenouvo, J. & Lenander-Lumikari, M.: Fungicidal effect of human lactoferrin against Candida albicans. FEMS Microbiol. Lett. 90: 223-228, 1992.
33. Tenouvo, J.: Nonimmunoglobulin defense factors in human saliva. In: Tenouvo, J. (Ed.): Human Saliva: Clinical Chemistry and Microbiology, Vol. II. CRC Press, Boca Raton, EL 1989, pp. 55-91.
34. Tenouvo, J., Lumikari, M. & Soukka, T.: Salivary lysozyme, lactoferrin and peroxidases. Antibacterial effect on carciogenic bacteria and clinical application in preventive dentistry. Proc. Finn. Dent. Soc. 87: 197-208, 1991.
35. Tobgi, S. T., Samaranayake, L. P. & MacFarlane, T. W.: The in vitro susceptibility of Candida species to lysozyme. Oral. Microbiol. Immunol. 2: 1-4, 1987.
36. Valenti, P., Visca, P., Antonini, G. & Orsi, N.: Interaction between lactoferrin and ovotransferrin and Candida cells. FEMS Microbiol. Lett. 33: 271-275, 1986.
37. Weinberg, E. D.: Iron and infection. Microbiol. Rev. 42: 45-66, 1978.
38. Yamada, Y. & Kondo, K.: Taxonomic significance of the coenzyme Q system in yeasts and yeast-like fungi. In: Iwata, K. (Ed.): Yeasts and yeast like organisms in medical science. Proceedings of the Tokyo International Special Symposium on Yeasts. 1972, pp. 61-69.